CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project develops a rapid and cost-effective point-of-care test for detecting SARS-CoV-2 in nasal and saliva samples. Utilizing advanced nanobody technology and surface plasmon resonance, the test aims to provide results in under 30 minutes, enhancing COVID-19 management and response.
The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections has led to more than 7.031.249 cases and 403.112 deaths globally as of June 8, 2020.
Although most infections are self-limited, about 15% of infected adults develop severe pneumonia that requires treatment with supplemental oxygen and an additional 5% progress to critical illness with hypoxaemic respiratory failure, acute respiratory distress syndrome, and multiorgan failure that necessitates ventila…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Marseille
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Belgium, Louvain La Neuve
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Ireland, MONKSTOWN DUBLIN
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
